Clinical Trials on Epilepsy, Partial

Total 6463 results

Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

Epilepsy | Seizures | Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

Epilepsy

United States, Ukraine, Hong Kong, Czechia
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures

Epilepsy | Partial Seizures

Japan
UCB Pharma

Completed

Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures (PASS)

Epilepsies, Partial

France, Germany, United Kingdom, Spain, Netherlands
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Epilepsy | Seizures | Epilepsies, Partial
Cyberonics, Inc.

Terminated

Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures

Epilepsies, Partial

United States
University of North Carolina, Chapel Hill
Focused Ultrasound Foundation

Recruiting

A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy

Partial Seizures With Secondary Generalization

United States
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

Epilepsy | Partial Onset Seizures

Japan
UCB Japan Co. Ltd.

Completed

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

Epilepsy | Partial Onset Seizures

Japan
Stanford University
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

Transcranial Magnetic Stimulation for BECTS (TMS4BECTS)

Learning Disorders | Benign Epilepsy With Centrotemporal Spikes | Language Problems

United States
Neurona Therapeutics
California Institute for Regenerative Medicine (CIRM)

Recruiting

FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

United States
Central Hospital, Nancy, France

Recruiting

Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients (CARTA)

Cognitive Decline | Epilepsy, Temporal Lobe

France
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization (Mozart)

Epilepsy | Partial Seizures
UCB Pharma

Completed

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Epilepsy
El Instituto Nacional de Neurologia y Neurocirugia...

Completed

CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients (CBTvsSSRI)

Depression | Epilepsy, Temporal Lobe

Mexico
Eisai Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy

Epilepsy | Partial-onset Seizures
UCB Pharma SA
UCB Japan Co. Ltd.

Completed

Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures

Epilepsy | Partial-onset Seizures

China, Japan
UCB Japan Co. Ltd.

Completed

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Epilepsy | Partial-onset Seizures

Japan
UCB Biopharma SRL

Enrolling by invitation

A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Epilepsy | Partial Seizures With or Without Secondary Generalization

China, Japan
Emory University
Baxter Healthcare Corporation

Terminated

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Seizure Disorder | Epilepsy, Partial | Epilepsy, Cryptogenic | Autoimmune Diseases, Nervous System | Limbic Encephalitis

United States
Michael A. Gelfand, MD, PhD
Epilepsy Foundation

Completed

Novel Helmet Design in Patients With Seizures

Generalized Tonic Clonic Seizure | Drug Resistant Epilepsy | Drop Seizures | Complex Partial Seizure | Fall Due to Seizure

United States
UCB Pharma SA
UCB Japan Co. Ltd.

Completed

A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures

Epilepsy | Partial Onset Seizures

China, Japan
UCB Japan Co. Ltd.
Parexel

Completed

Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures

Epilepsy | Partial-onset Seizures

Japan
Eisai Pharmaceuticals India Pvt. Ltd

Completed

A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older

Epilepsy | Partial Onset Seizures

India
University Hospital Schleswig-Holstein

Completed

Lacosamid-i.v.-Register (LCM)

Epilepsy With Partial Onset Seizures With or Without Secondary Generalization

Germany
UCB Biopharma SRL

Completed

A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

Epilepsy | Partial Seizures With or Without Secondary Generalization

China, Japan, Malaysia, Philippines, Singapore, Taiwan, Thailand
UCB Biopharma S.P.R.L.

Completed

A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Epilepsy | Partial Seizures With or Without Secondary Generalization

Japan
Assistance Publique - Hôpitaux de Paris

Recruiting

Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus (AudiCog)

Tinnitus | Epilepsy, Temporal Lobe

France
National Institute of Neurological Disorders and...

Completed

GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression

Depression | Epilepsy | Depressive Disorder, Major | Epilepsy, Temporal Lobe

United States
UCB Biopharma S.P.R.L.

No longer available

Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures

Epilepsies, Partial
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Malignant Glioma | WHO Grade 3 Glioma | Intractable Epilepsy | Seizure Disorder | WHO Grade 2 Glioma

United States
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital

Completed

Pharmacokinetics of Two Formulation of Pregabalin

Fibromyalgia | Diabetic Peripheral Neuropathy | Partial Seizure Disorder

Taiwan
National Institute of Neurological Disorders and...

Completed

Light Scattering Spectroscopy to Determine Brain Tumors

Epilepsy, Temporal Lobe | Temporal Lobe

United States
Eisai Inc.

Recruiting

A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

Partial-onset Seizures | Pediatric Epileptic Syndrome

United States, Spain, France, Belgium, Czechia, Denmark, Germany
Hospices Civils de Lyon

Unknown

Core Cerebrospinal Fluid Biomarker Profile in Anti-Leucine Rich Glioma Inactivated 1 (Anti-LGI1) Encephalitis (LGI1biom)

Encephalitis | LGI1 Antibody Associated Encephalitis
Eisai Inc.

Completed

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Epilepsy | Primary Generalized Tonic-Clonic Seizures | Partial-Onset Seizures
NaviFUS Corporation
Taipei Veterans General Hospital, Taiwan

Completed

Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy

Drug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant Epilepsy

Taiwan
Dutch Epilepsy Clinics Foundation

Unknown

Second-Line Treatment Choice for Epilepsy

Adults With Tonic Clonic Seizures and/or Partial Seizures

Netherlands
University of British Columbia

Terminated

Flunarizine for Treatment Resistant Absence Epilepsy

Juvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence Epilepsy

Canada
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Ketogenic Diet in Pediatric Intractable Epilepsy

Epilepsy Intractable | Epilepsy in Children

China
UCB Pharma SA

Completed

Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.

Epilepsy, Tonic-clonic

Poland, Sweden, Hungary, Czechia
UCB Pharma

Completed

Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.

Epilepsy, Tonic-clonic
LivaNova

Withdrawn

XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU) (XLTCS)

Epilepsy, Tonic-Clonic

Belgium
GlaxoSmithKline

Completed

Topiramate Bioequivalence Study Brazil - Fast

Epilepsy, Tonic-Clonic

Brazil
NYU Langone Health

Recruiting

Human Epilepsy Project 3 (HEP3)

Idiopathic Generalized Epilepsy

United States, Australia
University Hospital, Montpellier

Recruiting

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Intractable Epilepsy

Refractory Epilepsy

France
Boston Children's Hospital

Recruiting

Effects of Green Light Exposure on Epileptic Spikes in Patients With Refractory Epilepsy

Epilepsy | Epilepsy Intractable

United States
PhytoTech Therapeutics, Ltd.

Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy

Epilepsy Intractable

Israel
Institut National de la Santé Et de la Recherche...

Completed

Blinking and Yawning in Epilepsy: The Role of Dopamine (BYE BYE DOPA)

Idiopathic Generalized Epilepsy

France

Clinical Trials on Epilepsy, Partial

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations